Clinical Trial Update: Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine [Phase 2]

View source ↗

Summary

Phase 2 safety and immunogenicity study update for a live Francisella tularensis vaccine targeting tularemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tularemia

Drugs mentioned

• Francisella tularensis vaccine (live)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Tularemia | Phase 2 | Status: UNKNOWN